ChromaSol's LightGuard Technology

The problem at hand is the rapid spread of COVID-19 virus and dealing with treating those infected, those at risk, the bottle-necks in getting supplies, medications, protective gear, medical staff and the resulting panic. We have a simple, readily scaled technology that produces a novel airborne antimicrobial agent that self-sanitizes fabric and surfaces, and can safely be inhaled to treat bacterial and viral respiratory infections. It can be quickly and widely distributed by those with minimal training, and people can easily use it to self-medicate with minimal instruction with no danger of over-dosing. It has shown itself effective against viral infections like cold and flu of various strains and should have a good chance of being effective against COVID-19 (We have not been able to test against COVID-10).  It could let people get treatment quickly and have the satisfaction of helping themselves.

Covid-19 may become a global pandemic. People all over the world are in panic mode over "corona virus" hoarding masks, food, bottled water and other supplies. Masks are sold out and on back order. Medical professionals have masks on back order. The world lacks the infrastructure to deal with this . The supply chain going from securing materials for masks, protective gear, medication and vaccines to delivering these to the ones who need them is long with many bottle necks. Viral respiratory infections are difficult to treat. Medication is expensive.Vaccines must be designed for a specific pathogen and tested for safety and effectiveness. All this takes time and meanwhile the disease continues to spread. Our solution simplifies the supply chain and removes several bottle-necks and can utilize people of lesser skills and training to distribute directly to those in need and instruct in usage. People affected can learn to self-medicate with no danger of overdose.

We propose a polymer-bound photosensitizer in aqueous form that can be made in tanker truck quantities by conventional processes, packed in small quantities and diluted 1:5 with water.This can be used to treat bandanas to make a simple, make-shift mask that can be worn over the mouth and nose, and deliver the singlet oxygen for inhalation to treat COVID-19 or other respiratory infections. Individuals could make their own mask and self-medicate much more quickly than medical professionals could administer conventional medications. Other clothing/towels, etc could also be made self-sanitizing. Only water and sunshine are needed to utilize this technology. This would eliminate the bottle neck of making "proper" masks and getting the most treatment to the most people most quickly and least expensively. Meanwhile, masks can also be made and distributed.

Our solution will serve those infected with COVID-19 as well as those infected with various "Bird Flu" , "Swine Flu", common cold virus, and other bacterial and viral respiratory infections. It has also shown benefit in reducing mortality from respiratory disease in poultry and pig farms. The diluted product is sprayed on bedding or even the animals themselves. African Swine Flu has devastated pork farms throughout Africa and Asia putting food supplies at risk. Avian Flu has devastated poultry operations around the world. This could greatly reduce flock/herd mortality.

For those infected, this simple, inexpensive treatment can speed their recovery and possibly save lives. It could be more readily accessible than medications requiring alcohol swabs, syringes or medical personnel to administer.

The Challenge is to find a way to approach the COVID-19 epidemic to treat those infected and reduce its spread. The target population is those at risk of becoming infected and those already infected. That would potentially include most of the world's population. Our solution is simple, inexpensive and can be widely distributed to reach many people very quickly. It can be distributed by minimally trained lay-persons, leaving medical professionals to focus on the more seriously ill. People can self-medicate with minimal instruction. It eliminates the bottle-necks of making masks, vaccines, medications and medical staff availability

We are using singlet oxygen as an airborne antimicrobial agent that can be inhaled to treat bacterial and viral respiratory infections. The only breakdown or residual material is oxygen. There are no heavy metals of toxic chemicals involved.

We employ a photosensitizer embedded in a polymer matrix that can be modified to suit the application. The photosensitizer is a nano-scale molecular device that is powered by light and fueled by air. It absorbs energy from light and transfers it to oxygen in the air around it. The oxygen absorbs the energy and goes to an electronically excited stare with increased reactivity.It can be inhaled and has a lifetime of a second or so before relaxing to ground state. It appears to oxidize pathogens on contact. We believe it may elicit an immune response in the body to attack the infection.